THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
Highly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases (arterial hypertension, arrhythmia, Marfan syndrome, hypertrophic cardiomyopathy). β-AB fall into the category C according to safety classification of Food and Drug Administration (US FDA). Their prescri...
Saved in:
| Main Authors: | R. I. Striuk, Ya. V. Brytkova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoepidemiological Beta-blockers consumer research in Ukraine
by: O. Ya. Mishchenko, et al.
Published: (2012-12-01) -
THE PLACE FOR A NEW NATIONAL2MADE ΑΒ2BLOCKER, PROXODOLOL, IN THE TREATMENT OF HYPERTENSIVE CRISES
by: M. V. Leonova
Published: (2002-10-01) -
EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01) -
Hypertrophic Cardiomyopathy in a Fetus: A Rare Presentation Case Report
by: Alireza Golbabaei, et al.
Published: (2025-07-01) -
Choosing therapeutic tactics in pregnant women with chronic arterial hypertension: the priorities
by: N. G. Pivonova, et al.
Published: (2009-08-01)